Furthermore, resistin levels were associated with severity of PAD, reduced amputation-free survival, and an increased rate of major adverse cardiac events, suggesting that resistin may be a novel biomarker and prognostic indicator in PAD patients [35,36]. Here, RETN is linked to peripheral arterial disease.